{"id":264,"date":"2020-10-26T16:46:19","date_gmt":"2020-10-26T16:46:19","guid":{"rendered":"https:\/\/www.melanomadays.org\/?page_id=264"},"modified":"2020-10-30T06:08:33","modified_gmt":"2020-10-30T06:08:33","slug":"programme-day-1","status":"publish","type":"page","link":"https:\/\/www.melanomadays.org\/en\/programme-day-1\/","title":{"rendered":"Programme &#8211; Day 1"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\"><span class=\"has-inline-color has-vivid-cyan-blue-color\">DAY 1<\/span><\/h2>\n\n\n\n<p>Central and South-East European Melanoma Expert Group (CSEEMEG) regional meeting.<\/p>\n\n\n\n<hr class=\"wp-block-separator is-style-wide\"\/>\n\n\n\n<table id=\"tablepress-1\" class=\"tablepress tablepress-id-1\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">PRVI DAN \/ DAY 1<\/th><th class=\"column-2\">\u00a026.11.2020.<\/th><td class=\"column-3\"><\/td>\n<\/tr>\n<\/thead>\n<tbody>\n<tr class=\"row-2\">\n\t<td class=\"column-1\">09.30 - 09.40 <\/td><td class=\"column-2\">Opening of the meeting <\/td><td class=\"column-3\">Prof. dr Mirna \u0160itum, <br\/><br \/>\nDoc. dr Davorin Herceg dr.med, <br\/><br \/>\nProf. dr Lidija Kandolf Sekulovi\u0107<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">09.40 - 10.10<\/td><td class=\"column-2\">Opening lecture: Melanoma 2020: State of the art in the treatment of <br\/>metastatic disease<\/td><td class=\"column-3\">Prof. dr med. Axel Hauschild (Germany)<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">10.10 - 10.25 <\/td><td class=\"column-2\">Discussion<\/td><td class=\"column-3\"><\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">10.25 - 11.30 <\/td><td class=\"column-2\">Special clinical scenarios and best treatment options <br>(with discussion)<br \/>\n<\/td><td class=\"column-3\">Moderators: <br\/><br \/>\nProf. dr med. Axel Hauschild, <br\/><br \/>\nProf. dr Lidija Kandolf Sekulovi\u0107, <br\/><br \/>\nDoc. dr. Davorin Herceg dr.med, <br\/><br \/>\nAssoc. Professor Janja Ocvirk<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">10.30 - 10.40<\/td><td class=\"column-2\">Patient with oligometastatic disease. Luka Simeti\u0107 (Croatia)<\/td><td class=\"column-3\">Luka Simeti\u0107 (Croatia)<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">10.40 - 10.50<\/td><td class=\"column-2\">Patient with progression to targeted therapy<\/td><td class=\"column-3\">Prof. dr \u017deljko Miju\u0161kovi\u0107 (Serbia)<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">10.50 - 11.00<\/td><td class=\"column-2\">BRAFwt metastatic melanoma with progression on anti-PD1 monotherapy<\/td><td class=\"column-3\">Prof. dr Janja Ocvirk (Slovenia)<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">11.00 - 11.10<\/td><td class=\"column-2\">Patient with asymptomatic brain metastases<\/td><td class=\"column-3\">Doc. dr Davorin Herceg (Croatia)<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">11.10 - 11.20<\/td><td class=\"column-2\">Patient with symptomatic brain metastases<\/td><td class=\"column-3\">Prim. dr sc. Nina Dabeli\u0107 (Croatia)<\/td>\n<\/tr>\n<tr class=\"row-11\">\n\t<td class=\"column-1\">11.20 - 11.30<\/td><td class=\"column-2\">Discussion<\/td><td class=\"column-3\"><\/td>\n<\/tr>\n<tr class=\"row-12\">\n\t<td class=\"column-1\">11.30 - 12.00<\/td><td class=\"column-2\"><p style=\"color:blue\"><strong><u><a href=\"https:\/\/www.melanomadays.org\/en\/wp-content\/uploads\/sites\/2\/2020\/11\/Agenda-NVS-symposia-26.11.2020..pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Satellite symposium Novartis<\/a><\/strong><\/u><\/p><\/td><td class=\"column-3\"><\/td>\n<\/tr>\n<tr class=\"row-13\">\n\t<td class=\"column-1\">12.00 - 13.00<\/td><td class=\"column-2\"><p style=\"color:blue\"><strong><u><a href=\"https:\/\/www.melanomadays.org\/en\/wp-content\/uploads\/sites\/2\/2020\/11\/Pozivnica-Keytruda-Dani-melanoma-26.11.2020.-ENG.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Satellite symposium MSD<\/a><\/strong><\/u><\/p><\/td><td class=\"column-3\"><\/td>\n<\/tr>\n<tr class=\"row-14\">\n\t<td class=\"column-1\">13.00 - 14.30<\/td><td class=\"column-2\">Special clinical scenarios and best treatment options (with discussion)<\/td><td class=\"column-3\">Moderators: <br\/><br \/>\nProf.dr Nada Babovi\u0107 <br\/><br \/>\nProf. dr Janja Ocvirk <br\/><br \/>\nAcademician Prof. dr Mirna \u0160itum<\/td>\n<\/tr>\n<tr class=\"row-15\">\n\t<td class=\"column-1\">13.05 - 13.09<\/td><td class=\"column-2\">Patient with bone metastases<\/td><td class=\"column-3\">Dr sc. med Vladimir Vidovi\u0107 (Serbia) <\/td>\n<\/tr>\n<tr class=\"row-16\">\n\t<td class=\"column-1\">13.09 - 13.14<\/td><td class=\"column-2\">Patient with progression on second-line treatment<\/td><td class=\"column-3\">Dr Aleksandar Popovi\u0107 (Serbia)<\/td>\n<\/tr>\n<tr class=\"row-17\">\n\t<td class=\"column-1\">13.14 - 13.24<\/td><td class=\"column-2\">Patients with autoimmune diseases and chronic infections <\/td><td class=\"column-3\">Dr Dobrica Neri\u0107 (Serbia)<\/td>\n<\/tr>\n<tr class=\"row-18\">\n\t<td class=\"column-1\">13.24 - 13.34<\/td><td class=\"column-2\">Patient with grade 3 adverse reaction to immunotherapy. <\/td><td class=\"column-3\">Dr Suzana Matkovi\u0107 (Serbia)<\/td>\n<\/tr>\n<tr class=\"row-19\">\n\t<td class=\"column-1\">13.34 - 13.43<\/td><td class=\"column-2\">Patient with grade 3 cutaneous toxicity to targeted therapy: <br\/>Stevens-Johnson syndrome and TEN.<\/td><td class=\"column-3\">Doc. dr Tatjana Radevi\u0107 (Serbia)<\/td>\n<\/tr>\n<tr class=\"row-20\">\n\t<td class=\"column-1\">13.43 - 14.53<\/td><td class=\"column-2\">Patient with grade 3 cutaneous toxicity to immunotherapy<\/td><td class=\"column-3\">Prof. dr Du\u0161an \u0160kiljevi\u0107 (Serbia)<\/td>\n<\/tr>\n<tr class=\"row-21\">\n\t<td class=\"column-1\">13.53 - 14.00<\/td><td class=\"column-2\">Patient with vitiligo<\/td><td class=\"column-3\">Prim. dr sc. Da\u0161ka \u0160tulhofer Buzina (Croatia)<\/td>\n<\/tr>\n<tr class=\"row-22\">\n\t<td class=\"column-1\">14.00 - 14.10<\/td><td class=\"column-2\">Patient with changing melanocytic lesions during treatment. <\/td><td class=\"column-3\">Doc. dr sc. Marija Buljan (Croatia)<\/td>\n<\/tr>\n<tr class=\"row-23\">\n\t<td class=\"column-1\">14.10 - 14.30<\/td><td class=\"column-2\">Discussion<\/td><td class=\"column-3\">All participants <\/td>\n<\/tr>\n<tr class=\"row-24\">\n\t<td class=\"column-1\">14.30 - 15.40<\/td><td class=\"column-2\"><p style=\"color:blue\"><strong><u><a href=\"https:\/\/media.melanomadays.org\/2020\/11\/BMS_SATELIT-1.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Satellite symposium Bristol  Myers Squibb<\/a><\/strong><\/u><\/p><\/td><td class=\"column-3\"><\/td>\n<\/tr>\n<tr class=\"row-25\">\n\t<td class=\"column-1\">15.40 - 16.00<\/td><td class=\"column-2\">Pause<\/td><td class=\"column-3\"><\/td>\n<\/tr>\n<tr class=\"row-26\">\n\t<td class=\"column-1\">16.00 - 17.00<\/td><td class=\"column-2\">EuMelaReg and CSEEREG melanoma treatment registries - first results<br\/><br \/>\n<\/td><td class=\"column-3\">Moderators: <br\/><br \/>\nAcademician prof. dr. Mirna \u0160itum, <br\/><br \/>\nDoc. dr. Davorin Herceg, <br\/><br \/>\nProf. dr Lidija Kandolf Sekulovi\u0107<\/td>\n<\/tr>\n<tr class=\"row-27\">\n\t<td class=\"column-1\">16.00 - 16.15<\/td><td class=\"column-2\">The EuMelaReg treatment registry<\/td><td class=\"column-3\">Prof. dr Michael Weichenthal (Germany)<\/td>\n<\/tr>\n<tr class=\"row-28\">\n\t<td class=\"column-1\">16.15 - 16.30<\/td><td class=\"column-2\">CSEEREG: review of the registry<\/td><td class=\"column-3\">Academician prof. dr. Mirna \u0160itum (Croatia)<\/td>\n<\/tr>\n<tr class=\"row-29\">\n\t<td class=\"column-1\">16.30 - 16.50<\/td><td class=\"column-2\">Treatment and outcomes in stage III and stage IV disease: first results from CSEEREG<\/td><td class=\"column-3\">Doc. dr. Davorin Herceg (Croatia) and Prof. dr Lidija Kandolf Sekulovi\u0107 <\/td>\n<\/tr>\n<tr class=\"row-30\">\n\t<td class=\"column-1\">16.50 - 17.00<\/td><td class=\"column-2\">Conclusions<\/td><td class=\"column-3\">All participants<\/td>\n<\/tr>\n<tr class=\"row-31\">\n\t<td class=\"column-1\"><\/td><td class=\"column-2\"><\/td><td class=\"column-3\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-1 from cache -->\n","protected":false},"excerpt":{"rendered":"<p>DAY 1 Central and South-East European Melanoma Expert Group (CSEEMEG) regional meeting.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-264","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Programme - Day 1 - Melanoma Days<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.melanomadays.org\/en\/programme-day-1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Programme - Day 1 - Melanoma Days\" \/>\n<meta property=\"og:description\" content=\"DAY 1 Central and South-East European Melanoma Expert Group (CSEEMEG) regional meeting.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.melanomadays.org\/en\/programme-day-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Melanoma Days\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-30T06:08:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.melanomadays.org\/en\/programme-day-1\/\",\"url\":\"https:\/\/www.melanomadays.org\/en\/programme-day-1\/\",\"name\":\"Programme - Day 1 - Melanoma Days\",\"isPartOf\":{\"@id\":\"https:\/\/www.melanomadays.org\/en\/#website\"},\"datePublished\":\"2020-10-26T16:46:19+00:00\",\"dateModified\":\"2020-10-30T06:08:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.melanomadays.org\/en\/programme-day-1\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.melanomadays.org\/en\/programme-day-1\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.melanomadays.org\/en\/programme-day-1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u041f\u043e\u0447\u0435\u0442\u043d\u0430\",\"item\":\"https:\/\/www.melanomadays.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Programme &#8211; Day 1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.melanomadays.org\/en\/#website\",\"url\":\"https:\/\/www.melanomadays.org\/en\/\",\"name\":\"Melanoma Days\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.melanomadays.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Programme - Day 1 - Melanoma Days","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.melanomadays.org\/en\/programme-day-1\/","og_locale":"en_US","og_type":"article","og_title":"Programme - Day 1 - Melanoma Days","og_description":"DAY 1 Central and South-East European Melanoma Expert Group (CSEEMEG) regional meeting.","og_url":"https:\/\/www.melanomadays.org\/en\/programme-day-1\/","og_site_name":"Melanoma Days","article_modified_time":"2020-10-30T06:08:33+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.melanomadays.org\/en\/programme-day-1\/","url":"https:\/\/www.melanomadays.org\/en\/programme-day-1\/","name":"Programme - Day 1 - Melanoma Days","isPartOf":{"@id":"https:\/\/www.melanomadays.org\/en\/#website"},"datePublished":"2020-10-26T16:46:19+00:00","dateModified":"2020-10-30T06:08:33+00:00","breadcrumb":{"@id":"https:\/\/www.melanomadays.org\/en\/programme-day-1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.melanomadays.org\/en\/programme-day-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.melanomadays.org\/en\/programme-day-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u041f\u043e\u0447\u0435\u0442\u043d\u0430","item":"https:\/\/www.melanomadays.org\/en\/"},{"@type":"ListItem","position":2,"name":"Programme &#8211; Day 1"}]},{"@type":"WebSite","@id":"https:\/\/www.melanomadays.org\/en\/#website","url":"https:\/\/www.melanomadays.org\/en\/","name":"Melanoma Days","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.melanomadays.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/pages\/264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/comments?post=264"}],"version-history":[{"count":4,"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/pages\/264\/revisions"}],"predecessor-version":[{"id":571,"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/pages\/264\/revisions\/571"}],"wp:attachment":[{"href":"https:\/\/www.melanomadays.org\/en\/wp-json\/wp\/v2\/media?parent=264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}